Oddo BHF - Cegedim SA (CGM) Cegedim : Un T1 correct, guidance réitérée

Report

Oddo BHF

Geoffroy Michalet

Cegedim : Un T1 correct, guidance réitérée

>CA T1 en hausse organique de 6% - Au titre du T1 2024, Cegedim a publié hier soir un CA de 155.9 M€ en hausse de 6.9% dont +6% en organique, +0.7% d’effet périmètre lié à l’acquisition de Visiodent (1er mars 2024) et +0.2% d’effet devises. Toutes les divisions contribuent à cette croissance sauf l’activité Logiciels & Services. Notons que les activités Cegedim Outsourcing, Audiprint et BSV (intégrées respectivement dans les divisions Logiciels & Services et Flux) on...

26/04/2024 1 FR

Underlying

Cegedim SA

Cegedim is a technology and services company. Co. supplies services, IT tools, specialized software, information flow and database management services to healthcare industries, pharmaceutical companies, healthcare professionals and insurance companies. Co.'s operations can be divided into three sectors: CRM and Strategic Data (optimizing marketing and sales strategies, namely through tools and databases for managing sales forces, returns on investment, market or prescriber studies); Healthcare Professionals (software publishing with availability of promotional information) and Insurance and Services (software publishing and management of healthcare reimbursement flows).

See profile

FR0000053506 Euronext Paris France

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Geoffroy Michalet

Other Reports on these Companies

GlobeNewsWire

Claude Bernard et Softway Medical annoncent la signature de leur premier contrat en Belgique avec le Réseau wallon Phare

Claude Bernard et Softway Medical annoncent la signature de leur premier contrat en Belgique avec le Réseau wallon Phare Un nouveau contrat à l’international qui permet aux deux partenaires d’asseoir un peu plus leur notoriété auprès des institutions hospitalières Boulogne-Billancourt, le 2 mai 2024 - , expert des bases de données médicales, est fier d’annoncer le renforcement de son partenariat historique avec l’éditeur Softway Medical -leader du secteur des établissements de santé en France- avec un premier réseau hospitalier en Belgique. A partir du 1er janvier 2025, les trois instituti...

May 2, 2024 May 2, 2024 1 EN

SmartInsider

Cegedim: 2 directors

Two Directors at Cegedim bought 33,213 shares at between 13.898EUR and 14.198EUR. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. T...

Free Trial

May 1, 2024 May 1, 2024 1 EN

GlobeNewsWire

Cegedim: INCREASE OF MEANS OF THE LIQUIDITY CONTRACT

Cegedim: INCREASE OF MEANS OF THE LIQUIDITY CONTRACT PRESS RELEASE Financial Information SHARE BUYBACK PROGRAMME INCREASE OF MEANS OF THE LIQUIDITY CONTRACT WITH KEPLER CHEUVREUX Boulogne-Billancourt, April 30, 2024 CEGEDIM SA (ISIN: FR0000053506) has entrusted Kepler Cheuvreux with the implementation of a liquidity contract for its ordinary shares admitted to trading on Euronext Paris, under a contract dated 8 June 2008, amended by an Addendum dated 14 February 2019 (Addendum No. 1), by an Addendum dated 8 October 2020 (Addendum No. 2) and by an Addendum dated 6 February 2023 (Adden...

April 30, 2024 April 30, 2024 1 EN

Credit Recommendations - May 2024

...

1h / 25m 1h / 25m 1 EN

Suivi des Recommandations - Mai 2024

...

1h / 31m 1h / 31m 1 FR

Martin Marandon-Carlhian ... (+2)

Martin Marandon-Carlhian
Stephane Houri

Infineon Technologies AG : A revision is virtually certain, perhaps below the current consensus, but how far can it reasonably go?

>The real question with the release is the guidance, not the figures themselves - Infineon is set to report its Q2 2024 results on Tuesday morning before trading, with a conference call at 9.30 a.m. CET. We expect results to be slightly ahead of the consensus thanks notably to a €/$ exchange rate that is slightly more favourable than anticipated, but that is not the main question. The real question with this release will be the 2024 guidance which in our view (and now...

5h / 49m 5h / 49m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN